|
 |
|
 |
 |
Name:
Sector:
Chief Executive:
|
Vanda Pharmaceuticals
Healthcare
Mihael Polymeropoulos, M.D.
|
|
|
Summary:
|
Vanda revitalizes and optimizes the development of
therapeutics by applying genetic and genomic sciences. Vanda's business
is to optimize and to discover compounds for its own clinical
development. In addition, Vanda seeks to apply its tools to
discovery/development partnerships with other drug companies.
|
|
|
Stage of Initial
Investment:
|
Venture |
Liquidity:
|
IPO
(NASDAQ: VNDA)
|
|
|
|
|
|
|
|
 |
| |
9605 Medical Center Drive
Suite
300
Rockville, MD 20850
Phone: 240.599.4500
Fax: 301.294.1900 |
|
 |
|
|
|
